Search results for "Heart failure"
Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes
Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016
Cardiac rehab uptake remains low, despite benefits
Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022
CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care
A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022
CBT for comorbid heart failure and depression may only work for the latter
The authors described the reduced anxiety and fatigue, improved social functioning, and better health-related quality of life as especially encouraging results in light of the negative findings of other trials.
https://immattersacp.org/weekly/archives/2015/10/06/6.htm
6 Oct 2015
ACP releases joint statement with ACC and AHA on heart failure
ACP, along with the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA), has released a clinical statement on heart failure.
https://immattersacp.org/weekly/archives/2010/07/27/8.htm
27 Jul 2010
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Starting anticoagulation for older patients with heart failure and atrial fibrillation at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved rates of all-cause cardiovascular readmission or stroke, a study found.
https://immattersacp.org/weekly/archives/2014/09/16/6.htm
16 Sep 2014
More clarity on myocarditis with mRNA COVID-19 vaccines
The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023
Medical therapy often not tried before ICDs in heart failure patients
Results of a trial suggest that at least some patients with heart failure are receiving ICDs needlessly and highlight the treatment gap between real-world management of heart failure with reduced ejection fraction and opportunities to improve care.
https://immattersacp.org/weekly/archives/2016/03/08/2.htm
8 Mar 2016